company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,225909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-329593000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,210847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-211546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,424633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2928000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,256613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-55502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,225909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-329593000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,210847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-216512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-211546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,424633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2928000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,228745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,256613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-55502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,262735000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102888000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-436000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-509310000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,384606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-158538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-386332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-386332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-230977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14249000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3168000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-213560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-213560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4837000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-332320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-56859000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-68750000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,200318000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,81496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,81496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,3000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-122971000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,57000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,135963000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-149840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-172443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-172443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4089000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1218000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-102945000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-106779000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,88127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,181239000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,181239000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-386339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,177000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,248643000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8698000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-213889000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-213889000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-226888000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-211827000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-211827000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8954000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-235523000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,46086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-11-03 13:35:18+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,288326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,407148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,407148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-155686000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-715932000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,459490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-15120000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-430401000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-430401000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-438434000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,424633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25761000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16918000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16918000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,27425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21090000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,46086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-17473000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30384000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4696000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-137825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,63000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110391000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-55813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-55813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-278000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-498000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2573000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,12790000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,19320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57743000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,130081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,130081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42557000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-143000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,138252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-158076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-158076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-226610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,498000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10458000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-213883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-213883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5628000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-236250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,33296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-08-03 17:46:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18709000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,283030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,355990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,355990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-131010000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-578107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1304000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,349099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11650000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-374588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-374588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-438156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,425131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23188000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4699000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20363000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,33296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-36793000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29628000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56413000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,110299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,110299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-151149000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,91000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1657000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-605000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2820000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,532000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,860000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,860000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12017000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42393000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,55485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37082000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,208116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-56000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171462000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6094000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,38479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1964000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36931000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-35929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-167481000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,266480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-142869000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1780000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-720409000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6325000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,458347000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-400386000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-400386000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2889000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10475000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-93697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,94885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-13758000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,180244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,180244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-548947000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,231000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,360521000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-38479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-340764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-340764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-709000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,925000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9073000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9073000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-147774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,35929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-11-08 16:08:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,73784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3058000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3058000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,258682000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,261740000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,261740000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-148021000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1721000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-671918000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,496484000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-188319000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-513207000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-513207000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4798000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-244571000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-67016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-32995000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9952000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36669000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-146139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99146000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103926000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103926000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-226000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2746000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,26165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62749000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3806000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29550000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,108902000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,108902000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-402808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,261375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-18589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-236838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-236838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,226000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6212000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-117744000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,24101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-08-09 12:37:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,47619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,235007000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,241556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,241556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136028000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1526000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-663604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,507729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-171899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-465094000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-465094000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4734000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-272000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1946000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2882000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-213814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-66054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-39840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4812000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,73642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,73642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-215930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-142000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,87000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3214000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77325000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11761000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22609000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24738000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34654000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-186878000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,150821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-15329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-86285000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-86285000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3464000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40419000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,12340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,25010000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,280207000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,278213000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,278213000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-578000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-598823000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,211000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,493895000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-170296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-395324000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-395324000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5197000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-2246000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10075000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4902000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4902000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18113000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22330000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-25367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,175476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112998000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-386714000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1214000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,565831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11237000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22754000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-311697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-311697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9805000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-131837000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-61233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-71144000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34060000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,6832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53735000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45785000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45785000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-32000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39758000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-61233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-130864000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,306702000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,184822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,184822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109441000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-565008000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7346000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,609922000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,38479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22702000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-311950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-311950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11722000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-134664000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-35929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-107761000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,245934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,174930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,174930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-309329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-309329000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-75206000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,101822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,98586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-393546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,512096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9397000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-24666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-315465000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-315465000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-171595000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 13:58:29+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,280841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,201332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,201332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125770000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1047000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-660319000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,463134000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,18589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-298114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-298114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-585000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-226000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10979000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-67000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-67000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-89488000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-24101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-183418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-37000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1062000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,124934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,75056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19227000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19227000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12681000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-11675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-56297000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43754000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-342718000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1088000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,266162000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-134566000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-134566000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-141000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,559000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96389000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-06 17:17:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-42102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34103000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-463000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-146971000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,141228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-75056000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-115339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-115339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-93000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94759000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,263144000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,251720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,251720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-142318000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1998000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-680502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6351000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,448754000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-59727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-429440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-429440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-679000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10282000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2654000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12017000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12017000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-165183000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-104512000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,273300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-165626000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-205746000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,196115000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-190511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-190511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2337000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15051000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1025000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12790000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-28939000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40204000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,9000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6686000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3625000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3625000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5739000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11342000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-60044000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,233096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-124510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15488000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-159607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,158157000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-141067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-141067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8365000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7051000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,93042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 18:15:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,31105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,309986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-158570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15688000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-152775000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,343000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,211892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-186852000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-186852000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10205000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2678000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,132800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-50476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-99759000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,90654000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,43000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14046000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,274164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-149920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15582000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-143069000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,464000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,414750000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11130000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9711000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-299263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-299263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8181000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-50321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-11983000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3024000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-527000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3049000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,286000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20163000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10150000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,142442000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15382000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99073000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,115081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-94556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-94556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-643000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6473000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1065000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,53119000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:15:54+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,240066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,220546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,220546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12595000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-285016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1302000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,470495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3002000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,74348000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,74348000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300251000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11526000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22678000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-311355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-311355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-72616000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-78430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23945000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12358000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45273000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35570000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3424000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,182000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32956000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,186200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-116356000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1372000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-298707000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,79000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,249487000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-166869000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-166869000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-282000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-31715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35942000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28853000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,3000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126267000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71301000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-76000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,368000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5682000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49780000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-9620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-47361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,150258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-172440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,41000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,178186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-206000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4726000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4853000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4853000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22058000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94078000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-02 17:25:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,190462000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-218579000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-115000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,216144000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132535000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132535000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1532000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8478000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8478000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16319000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,82736000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-1137000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-44398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,82279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-54000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,140000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1984000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2123000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2123000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9377000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,67979000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-111292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,29000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,118586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-55856000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-55856000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1725000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36882000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 17:20:02+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6269000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,198837000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-131964000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-217965000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-84000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,199620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-151811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-151811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3218000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10304000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,65463000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-1841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-39729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38533000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-14000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50731000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-65000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3080000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3061000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3061000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,9542000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7772000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29446000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27975000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1307000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66568000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67855000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11353000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,237176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-227041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,115000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,218078000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-182932000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-182932000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2287000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2978000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-903000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,61221000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-37351000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,216100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-141436000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-292586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,219879000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-213880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-213880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11280000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9020000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9020000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1618000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-22756000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-38442000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-50836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,121314000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,121314000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-108114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-217820000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,378000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,161799000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-163757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-163757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-231000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2406000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6191000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6191000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3358000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-09 16:12:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38488000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4033000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9319000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69397000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,357000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55377000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53429000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53429000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1953000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-712000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,26288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,71668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41517000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,69707000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,69707000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68348000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-148423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,106422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110328000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110328000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6875000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3294000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3294000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1571000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38898000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 15:28:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11085000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37578000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4459000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,77155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,20000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50866000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59470000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34090000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58621000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7448000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7448000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55556000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-77000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3768000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3433000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4114000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,104137000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-360301000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,86000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,299770000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-175572000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-175572000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-352000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1094000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-72188000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-22224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-52136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,69337000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,48801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126535000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-96000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7310000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4917000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54913000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-12315000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163928000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-233766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,62000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,235143000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-162489000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-162489000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-256000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3681000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3823000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-127101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-02 19:47:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-39821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21484000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90773000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,41000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-71000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2037000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-20755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-142444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-142993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,137741000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-147675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-147675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-185000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-395000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-395000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-134580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-10865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-09 13:48:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-19066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29571000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74688000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66970000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-73000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5852000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10919000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10262000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112873000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68305000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-164581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,54000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-8804000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,285494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-129828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-371019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,302590000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-186978000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-186978000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2961000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-48680000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-48680000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49181000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-22703000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-62414000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,105009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53874000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84193000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,42000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-47003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-47003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4574000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,180485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75954000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-286826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11237000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,219110000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132167000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132167000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1595000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1677000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1677000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3965000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-11721000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-01 17:01:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-57840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,249822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27153000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-413361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11261000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,283737000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-145250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-145250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1691000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21840000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-18250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-952000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,105519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-33945000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-70155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,218000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96152000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-90000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3746000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31504000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,118208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-183001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1505000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5108000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,499000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,499000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3053000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-11277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-06 14:03:10+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-47620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,216045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26583000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-400309000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11084000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,284987000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-130555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-130555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1672000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2037000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5231000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22636000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-80690000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121558000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4082000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1418000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4436000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-44375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40346000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6937000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62877000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1383000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22662000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-378000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-3245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,200683000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29441000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-353439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7008000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,291876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83996000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83996000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-327000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2183000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2183000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3815000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-46577000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,159802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-183997000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67109000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,75811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10949000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2447000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,457897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-98532000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-450836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8947000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,331532000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-208889000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-208889000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1129000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10573000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22758000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22758000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2237000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,228487000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-22330000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-45081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,298095000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76934000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-266839000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,264423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-75811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-147693000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-147693000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-973000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-20000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13571000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10573000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17975000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17975000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3239000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,129188000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-11381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-01 17:01:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-42634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,403104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-351032000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,347903000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-76077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-202504000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-202504000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2339000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-68912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16846000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10573000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-64978000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-64978000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7859000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,127763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22363000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-47208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,99750000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-1000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-59728000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109909000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4999000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5164000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-18618000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,198345000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171615000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7469000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,188288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7743000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5409000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13484000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13484000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,149204000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-11085000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 14:03:10+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-24016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,365631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-359633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,367920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16349000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-122104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-122104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2273000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-63913000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11241000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-62663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-62663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,179283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22511000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-38810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,155402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22214000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7395000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83391000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-23486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15001000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3976000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,145000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,124831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-10626000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-19449000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42943000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23629000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,74000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7403000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-237000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1433000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2161000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2161000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-459000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4567000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,288091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-404951000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4416000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,344610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7403000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-190875000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-190875000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3111000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11103000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-49034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-49034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2710000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50892000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-63736000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,477762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,16083000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-453612000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,334017000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-198598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-198598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2307000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-128005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17181000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-123536000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-123536000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5722000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,149906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-22102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-45042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21591000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107382000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1415000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1265000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-98617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-98617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,-231000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4528000.0
